The Schwabe Group comprises several different affiliated companies in the pharmaceutical and health industry. All of the companies within the Schwabe Group focus on plants as the basis for developing pharmaceuticals and health products.
The parent company of the Schwabe Group, which is now Dr. Willmar Schwabe GmbH & Co. KG, is one of the oldest pharmaceutical manufacturers in Europe with a company history dating back over 150 years.
In late 2016, approximately 3,600 people worked at the Schwabe Group, and sales totalled around €900 million.
The largest percentage of the Schwabe Group workforce is in Germany, where some 1,600 people are employed.
The Group headquarters are in Karlsruhe.
Over time, the role of global business activity has expanded, and today it has a major impact on the Group’s stability and growth. By late 2016, international business accounted for some 75% of the total sales of the Schwabe Group.
Today, the Schwabe Group is active on all five continents. One focus is on Europe, and for quite some time South and Central America as well as southeast Asia have been important markets as well. The US and China in particular have grown to be the most important international markets in the past several years.
The Schwabe Group is under the direction of Olaf Schwabe, who represents the fifth generation of the family and is the great-great grandson of the founder, Dr. Willmar Schwabe.
As the CEO, Olaf Schwabe leads the Group Executive Team, which consists of several members and is responsible for the fields of R&D, production, quality control, marketing, finance, HR and legal affairs around the world and throughout the corporate group.
The GET defines the global strategy of the group and is responsible for its operational management. Olaf Schwabe, Dr. Anke Balzer, Patrick Krauth, Dr. Rainer Oschmann and Joachim A. Thole constitute the GET of the Schwabe Group.
The GET is supported in its work by a seven-member advisory board. The members of the Advisory Board are Stefan Genten, Thorsten Klapproth, Katrin Lenz, Dr. Rinaldo Riguzzi (Chairman), Dr. Achim Schwabe, Markus W. Schwabe and Tilmann Wächter.